FR2686899B1
(fr)
*
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
IT1289608B1
(it)
*
|
1997-02-05 |
1998-10-15 |
Angelini Ricerche Spa |
Composizione per uso terapeutico o diagnostico somministrabile per via intranasale,sublinguale o vaginale
|
US6248358B1
(en)
|
1998-08-25 |
2001-06-19 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets and methods of making and using the same
|
US6624200B2
(en)
|
1998-08-25 |
2003-09-23 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
CA2312190A1
(en)
*
|
1997-12-05 |
1999-06-17 |
Eli Lilly And Company |
Glp-1 formulations
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
WO1999056537A2
(en)
*
|
1998-04-30 |
1999-11-11 |
The Horticulture And Food Research Institute Of New Zealand Limited |
Biological pest control methods and compositions
|
WO2000019978A2
(en)
|
1998-10-05 |
2000-04-13 |
The Penn State Research Foundation |
Compositions and methods for enhancing receptor-mediated cellular internalization
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
ATE537811T1
(de)
†
|
1999-02-08 |
2012-01-15 |
Intarcia Therapeutics Inc |
Stabile nicht wässerige einphasige visköse vehikel und formulierungen die diese vehikel verwenden
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6565879B1
(en)
|
1999-12-16 |
2003-05-20 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
|
US20030104041A1
(en)
*
|
1999-12-16 |
2003-06-05 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
US6558695B2
(en)
|
1999-12-16 |
2003-05-06 |
Dermatrends, Inc. |
Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
|
US20030153585A1
(en)
*
|
2000-01-13 |
2003-08-14 |
Sven-Alexander Schreder |
Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
|
US20050100991A1
(en)
*
|
2001-04-12 |
2005-05-12 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
EP2295456A1
(en)
*
|
2000-04-12 |
2011-03-16 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
US6528520B2
(en)
*
|
2000-08-15 |
2003-03-04 |
Cpd, Llc |
Method of treating the syndrome of coronary heart disease risk factors in humans
|
US6846831B2
(en)
|
2000-08-15 |
2005-01-25 |
Cpd, Llc |
Method of treating the syndrome of lipodystrophy
|
WO2002043566A2
(en)
*
|
2000-11-28 |
2002-06-06 |
Baum Martin G |
Devices and methods for treating low blood sugar levels
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
WO2002043709A1
(fr)
|
2000-12-01 |
2002-06-06 |
Takeda Chemical Industries, Ltd. |
Procede de production d'une preparation contenant une substance bioactive
|
EP1346726A4
(en)
*
|
2000-12-25 |
2004-09-15 |
Shiseido Co Ltd |
FRAGRANCE COMPOSITION STIMULATING THE SYMPATHETIC SYSTEM
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
JP4993652B2
(ja)
*
|
2004-03-31 |
2012-08-08 |
リンテック株式会社 |
経口投与剤
|
CN1462194B
(zh)
*
|
2001-04-24 |
2013-04-24 |
琳得科株式会社 |
口服给药制剂及口服给药制剂保持体
|
US8268333B2
(en)
*
|
2001-04-24 |
2012-09-18 |
Lintec Corporation |
Orally administered agent and an orally administered agent/supporting substrate complex
|
CA2446619C
(en)
*
|
2001-05-11 |
2011-04-26 |
Elan Corporation, Plc |
Permeation enhancers
|
US20030143191A1
(en)
*
|
2001-05-25 |
2003-07-31 |
Adam Bell |
Chemokine beta-1 fusion proteins
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
FR2827517B1
(fr)
*
|
2001-07-23 |
2003-10-24 |
Bioalliance Pharma |
Systemes therapeutiques bioadhesifs a liberation prolongee
|
US6642003B2
(en)
|
2001-08-02 |
2003-11-04 |
Cedars-Sinai Medical Center |
Human glucose-dependent insulin-secreting cell line
|
US20060073174A1
(en)
*
|
2001-08-16 |
2006-04-06 |
Access Pharmaceuticals, Inc. |
Adherent and erodible film to treat a moist surface of a body tissue
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7030082B2
(en)
*
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US7425292B2
(en)
*
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20070281003A1
(en)
*
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US20060039958A1
(en)
*
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
EP1463751B1
(en)
*
|
2001-12-21 |
2013-05-22 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
EP1463752A4
(en)
*
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
ALBUMIN FUSION PROTEINS
|
CA2472449C
(en)
|
2002-01-16 |
2010-03-09 |
Yamanouchi Pharmaceutical Co., Ltd. |
Pharmaceutical composition for oral use with improved absorption
|
NZ534125A
(en)
*
|
2002-02-20 |
2006-11-30 |
Emisphere Tech Inc |
A formulation comprising a GLP-1 compound and a delivery agent
|
US7141240B2
(en)
*
|
2002-03-12 |
2006-11-28 |
Cedars-Sinai Medical Center |
Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1
|
ATE385193T1
(de)
|
2002-03-20 |
2008-02-15 |
Mannkind Corp |
Inhalationsgerät
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US20030194420A1
(en)
*
|
2002-04-11 |
2003-10-16 |
Richard Holl |
Process for loading a drug delivery device
|
CN102188409A
(zh)
*
|
2002-07-22 |
2011-09-21 |
莫诺索尔克斯有限公司 |
速溶剂型的包装和分配
|
US20080260838A1
(en)
*
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
DE10240894A1
(de)
*
|
2002-09-04 |
2004-03-11 |
Procom Biotechnologische Produktions Gmbh |
Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut
|
US20040122110A1
(en)
*
|
2002-09-06 |
2004-06-24 |
Maccabee Mendy S. |
Effect of vitamin A gel on paranasal sinus mucosal regeneration
|
CA2501677A1
(en)
*
|
2002-10-22 |
2004-05-06 |
Waratah Pharmaceuticals, Inc. |
Treatment of diabetes
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
US8088734B2
(en)
*
|
2003-01-21 |
2012-01-03 |
Unigene Laboratories Inc. |
Oral delivery of peptides
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7306812B2
(en)
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
ATE549028T1
(de)
*
|
2003-05-15 |
2012-03-15 |
Tufts College |
Stabile analoga von glp-1
|
US20040241223A1
(en)
*
|
2003-05-27 |
2004-12-02 |
David Wong |
Oral dosage forms for macromolecular drugs
|
US20060286129A1
(en)
*
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
AU2005207870B2
(en)
*
|
2004-01-30 |
2010-08-19 |
Waratah Pharmaceuticals, Inc. |
The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels
|
US7906137B2
(en)
*
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
WO2006014673A2
(en)
|
2004-07-19 |
2006-02-09 |
Nobex Corporation |
Insulin-oligomer conjugates, formulations and uses thereof
|
KR101273120B1
(ko)
|
2004-08-20 |
2013-06-13 |
맨카인드 코포레이션 |
다이케토피페라진 합성의 촉매 작용
|
ES2540886T3
(es)
|
2004-08-23 |
2015-07-14 |
Mannkind Corporation |
Sales de dicetopiperazina para la administración de fármacos
|
US7442682B2
(en)
*
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US8052996B2
(en)
|
2005-02-03 |
2011-11-08 |
Intarcia Therapeutics, Inc. |
Two-piece, internal-channel osmotic delivery system flow modulator
|
CN101193652B
(zh)
*
|
2005-04-08 |
2011-11-02 |
安米林药品公司 |
包含肠降血糖素肽和非质子极性溶剂的药物制剂
|
DE102005033943A1
(de)
*
|
2005-07-20 |
2007-02-22 |
Hexal Ag |
Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
|
CN104324366B
(zh)
|
2005-09-14 |
2016-10-05 |
曼金德公司 |
以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
|
JP2009523672A
(ja)
*
|
2006-01-20 |
2009-06-25 |
モノソル アールエックス リミテッド ライアビリティ カンパニー |
フィルムライニングを施した、包装体およびその製法
|
JP2009523808A
(ja)
*
|
2006-01-20 |
2009-06-25 |
モノソル アールエックス リミテッド ライアビリティ カンパニー |
活性物質の粘膜投与のためのフィルム包帯
|
ES2647080T3
(es)
|
2006-02-22 |
2017-12-19 |
Mannkind Corporation |
Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo
|
CN101489756B
(zh)
*
|
2006-03-24 |
2013-08-07 |
奥克思利尤姆国际控股公司 |
热熔挤出层压材料的制备方法
|
EP1837020A1
(en)
|
2006-03-24 |
2007-09-26 |
Bioalliance Pharma |
Mucosal bioadhesive slow release carrier for delivering active principles
|
JP5536446B2
(ja)
|
2006-03-24 |
2014-07-02 |
オクシリウム インターナショナル ホールディングス,インコーポレイティド |
アルカリ不安定ドラッグを含む安定化された組成物
|
MX2008012678A
(es)
*
|
2006-04-07 |
2008-12-17 |
Merrion Res Iii Ltd |
Forma de dosis oral solida que contiene un mejorador.
|
EP2040731A4
(en)
*
|
2006-06-09 |
2010-05-19 |
Merrion Res Iii Ltd |
SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
JP4739452B2
(ja)
*
|
2006-09-20 |
2011-08-03 |
モノソル アールエックス リミテッド ライアビリティ カンパニー |
発泡を減じる風味付与剤を含む喫食可能な水溶性フィルム
|
JP5356235B2
(ja)
*
|
2006-09-29 |
2013-12-04 |
モノソル アールエックス リミテッド ライアビリティ カンパニー |
フィルム−埋設包装およびその製造方法
|
US20080260823A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Sciele Pharma, Inc. |
Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
|
IL290847B2
(en)
|
2007-04-23 |
2024-11-01 |
Intarcia Therapeutics Inc |
Suspension formulations of insulinotropic peptides and their uses
|
DK2155229T3
(da)
*
|
2007-05-01 |
2011-05-09 |
Cephalon Inc |
Sammensætning til transmukosal indgivelse af polypeptider
|
US20080292683A1
(en)
*
|
2007-05-24 |
2008-11-27 |
Monosolrx, Llc. |
Film shreds and delivery system incorporating same
|
PL2203181T3
(pl)
|
2007-10-16 |
2018-07-31 |
Biocon Limited |
Podawana doustnie stała kompozycja farmaceutyczna i jej sposób
|
US8298583B2
(en)
|
2007-10-19 |
2012-10-30 |
Monosol Rx, Llc |
Film delivery system for tetrahydrolipstatin
|
JP2011500850A
(ja)
*
|
2007-10-24 |
2011-01-06 |
マンカインド コーポレイション |
Glp−1による副作用を防止する方法
|
US8343140B2
(en)
|
2008-02-13 |
2013-01-01 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
AU2009244797B2
(en)
*
|
2008-05-07 |
2015-01-22 |
Merrion Research Iii Limited |
Compositions of peptides and processes of preparation thereof
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
DK2293833T3
(en)
|
2008-06-13 |
2016-05-23 |
Mannkind Corp |
DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
|
CA2728523C
(en)
|
2008-06-20 |
2020-03-10 |
Mannkind Corporation |
An interactive apparatus and method for real-time profiling of inhalation efforts
|
CA2731236A1
(en)
*
|
2008-07-21 |
2010-01-28 |
Transpharma Medical Ltd. |
Transdermal system for extended delivery of incretins and incretin mimetic peptides
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
US20100040727A1
(en)
*
|
2008-08-18 |
2010-02-18 |
Monosol Rx, Llc |
Method for Improving Uniformity of Content in Edible Film Manufacturing
|
EP2165706A1
(en)
|
2008-09-18 |
2010-03-24 |
BioAlliance Pharma |
Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
|
US8282954B2
(en)
*
|
2008-12-15 |
2012-10-09 |
Monosol Rx, Llc |
Method for manufacturing edible film
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
AR075613A1
(es)
*
|
2009-02-25 |
2011-04-20 |
Merrion Res Iii Ltd |
Composicion y suministro de drogas de bifosfonato. metodo de tratamiento
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
DK2405963T3
(da)
|
2009-03-11 |
2013-12-16 |
Mannkind Corp |
Apparat, system og fremgangsmåde til at måle modstand i en inhalator
|
US20100285130A1
(en)
*
|
2009-05-06 |
2010-11-11 |
Monosol Rx, Llc |
Coating of complexed actives in film formulations
|
US20100297232A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Monosol Rx, Llc |
Ondansetron film compositions
|
SG176738A1
(en)
|
2009-06-12 |
2012-01-30 |
Mannkind Corp |
Diketopiperazine microparticles with defined specific surface areas
|
US8475832B2
(en)
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
RU2753280C2
(ru)
|
2009-09-28 |
2021-08-12 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
EA022040B1
(ru)
*
|
2009-11-12 |
2015-10-30 |
Экейше Фарма Лимитед |
Применение бетанехола для лечения ксеростомии
|
BR112012012945A2
(pt)
|
2009-11-25 |
2020-12-29 |
Arisgen Sa |
Composição de liberação mucosal, seu método de produção, complexo de peptídeo pré-formado, kit e uso de um agente ativo de peptídeo
|
WO2011072208A1
(en)
*
|
2009-12-10 |
2011-06-16 |
Monosol Rx, Llc |
Ph sensitive compounds in taste masking within oral thin film strips
|
US20110142889A1
(en)
*
|
2009-12-16 |
2011-06-16 |
Nod Pharmaceuticals, Inc. |
Compositions and methods for oral drug delivery
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
US9089484B2
(en)
*
|
2010-03-26 |
2015-07-28 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
|
WO2011123943A1
(en)
|
2010-04-09 |
2011-10-13 |
Mount Sinai Hospital |
Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
|
EP2579844B1
(en)
|
2010-06-10 |
2016-02-24 |
Midatech Ltd. |
Nanoparticle film delivery systems
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US8802114B2
(en)
|
2011-01-07 |
2014-08-12 |
Merrion Research Iii Limited |
Pharmaceutical compositions of iron for oral administration
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
AU2012236150B2
(en)
|
2011-04-01 |
2016-03-31 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
GB201107533D0
(en)
|
2011-05-06 |
2011-06-22 |
Acacia Pharma Ltd |
Formulaiton
|
EP2526971A1
(en)
*
|
2011-05-25 |
2012-11-28 |
ArisGen SA |
Mucosal delivery of drugs
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
GB201200062D0
(en)
*
|
2012-01-04 |
2012-02-15 |
Innotesto Bvba |
Estradiol oromucosal liquid compositions
|
EP2861220A2
(en)
*
|
2012-06-14 |
2015-04-22 |
Entrega, Inc. |
Mucoadhesive devices for delivery of active agents
|
EP2873422A4
(en)
|
2012-07-10 |
2015-12-30 |
Takeda Pharmaceutical |
PHARMACEUTICAL PREPARATION FOR INJECTION
|
CN108057154B
(zh)
|
2012-07-12 |
2021-04-16 |
曼金德公司 |
干粉药物输送系统和方法
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
US10421729B2
(en)
|
2013-03-15 |
2019-09-24 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
AU2014271645B2
(en)
*
|
2013-05-31 |
2016-11-10 |
Hisamitsu Pharmaceutical Co., Inc. |
Oral cavity patch
|
US9925144B2
(en)
|
2013-07-18 |
2018-03-27 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
WO2015132660A1
(en)
*
|
2014-03-04 |
2015-09-11 |
Eastgate Pharmaceuticals Inc. |
Pharmaceutical composition for transmucosal delivery and methods for treating diabetes in a subject in need thereof
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
WO2016120378A1
(en)
|
2015-01-29 |
2016-08-04 |
Novo Nordisk A/S |
Tablets comprising glp-1 agonist and enteric coating
|
CN107920884B
(zh)
|
2015-06-03 |
2021-08-27 |
因塔西亚制药公司 |
植入物放置和移除系统
|
JP7083312B2
(ja)
*
|
2016-04-26 |
2022-06-10 |
エルテーエス ローマン テラピー-ジステーメ アーゲー |
抗糖尿病ペプチドの経粘膜送達用のフィルム状投与形態
|
BR112018072539A2
(pt)
|
2016-05-05 |
2019-03-26 |
Aquestive Therapeutics, Inc. |
composições de epinefrina de administração aumentada
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
WO2017200943A1
(en)
|
2016-05-16 |
2017-11-23 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CN106177874A
(zh)
*
|
2016-08-30 |
2016-12-07 |
郑州市久久不忘生物技术有限公司 |
一种治疗咳喘的药物贴片及其制备方法
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|